Nuveen Asset Management LLC Has $4.35 Million Stake in Trupanion, Inc. (NASDAQ:TRUP)

Nuveen Asset Management LLC lessened its stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 21.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 90,213 shares of the financial services provider's stock after selling 24,387 shares during the period. Nuveen Asset Management LLC owned about 0.21% of Trupanion worth $4,348,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Balyasny Asset Management L.P. boosted its stake in Trupanion by 368.2% in the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock worth $40,548,000 after purchasing an additional 661,559 shares during the period. BNP Paribas Financial Markets grew its holdings in shares of Trupanion by 170.7% during the fourth quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock valued at $16,248,000 after buying an additional 212,545 shares in the last quarter. Freestone Grove Partners LP purchased a new stake in Trupanion in the 4th quarter worth about $7,776,000. Baillie Gifford & Co. lifted its stake in Trupanion by 26.6% in the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock worth $33,806,000 after acquiring an additional 147,341 shares in the last quarter. Finally, First Trust Advisors LP purchased a new position in Trupanion during the 4th quarter valued at about $7,083,000.

Insider Buying and Selling

In other Trupanion news, CFO Fawwad Qureshi sold 828 shares of the firm's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $45.53, for a total value of $37,698.84. Following the sale, the chief financial officer now directly owns 6,079 shares in the company, valued at $276,776.87. This trade represents a 11.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO John R. Gallagher sold 4,000 shares of the business's stock in a transaction dated Thursday, May 29th. The stock was sold at an average price of $47.90, for a total transaction of $191,600.00. Following the transaction, the chief operating officer now owns 26,966 shares in the company, valued at approximately $1,291,671.40. The trade was a 12.92% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 41,487 shares of company stock worth $1,538,966. 5.42% of the stock is currently owned by insiders.

Trupanion Stock Down 1.5%

Shares of Trupanion stock traded down $0.76 during midday trading on Wednesday, reaching $48.62. 109,150 shares of the company's stock traded hands, compared to its average volume of 608,343. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. Trupanion, Inc. has a 52 week low of $25.90 and a 52 week high of $57.90. The company's 50 day simple moving average is $40.31 and its 200 day simple moving average is $43.80. The company has a market cap of $2.08 billion, a price-to-earnings ratio of -211.39, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.02. The company had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The business's revenue was up 11.7% compared to the same quarter last year. During the same period last year, the company earned ($0.16) earnings per share. Equities analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on TRUP. Stifel Nicolaus decreased their price target on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a report on Thursday, February 20th. Lake Street Capital dropped their price target on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Finally, Piper Sandler cut their price objective on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $51.80.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.